{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380865814747143702.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Kazuhito Suzuki"}],"foaf:familyName":[{"@value":"Suzuki"}],"foaf:givenName":[{"@value":"Kazuhito"}]}],"career":[{"institution":{"notation":[{"@value":"Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Minato City 105-8461, Tokyo, Japan"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360865814747144064","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.3390/life14030389"},{"@type":"URI","@value":"https://www.mdpi.com/2075-1729/14/3/389/pdf"}],"notation":[{"@value":"Daratumumab Treatment for “Truly Frail” Elderly Myeloma Patients"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.3390/life14030389_WjfIn68VTeoXQiXaPtz7DizkKFB"},{"@type":"OPENAIRE","@value":"doi_dedup___::096b113b1cf39f0afecb330e33c9b7e3_WjfIn68VTeoXQiXaPtz7DizkKFB"}]}